Affiliate disclosure: The RX Index earns a commission when you sign up with some of the providers mentioned on this page. It does not affect what you pay, and it never determines our rankings or which providers we cover. Read the full disclosure.

By The RX Index Editorial TeamLast verified: May 28, 2026Next review: June 2026Source: CMS

Does Medicare GLP-1 Bridge Cover Zepbound Vials?

Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.

No. The Medicare GLP-1 Bridge does not cover Zepbound vials. It covers the Zepbound KwikPen only. The single-dose vials — including the cheaper ones from LillyDirect — and the single-dose pens are left out. Here’s the part that trips everyone up: these are all FDA-approved Zepbound, with the same active ingredient (tirzepatide). CMS simply made one Zepbound format eligible for this program.

Your Zepbound prescription	Covered by the Bridge?	What to do
Zepbound KwikPen	✅ Yes, if you qualify	Confirm the NDC + file the Bridge prior authorization
Zepbound single-dose vial	❌ No	Ask about switching to KwikPen, or keep paying self-pay
Zepbound single-dose pen	❌ No	Ask about switching to KwikPen, or use another path
Zepbound for sleep apnea	❌ Not through the Bridge	Goes through regular Part D instead

Source: CMS Medicare GLP-1 Bridge lists only the KwikPen formulation of Zepbound for the Bridge and says the single-dose vial and single-dose pen will not be available.

Check my Zepbound path — free, about 60 seconds →

Tell us your product and we'll point you to the right path before you call your doctor.

Does the Medicare GLP-1 Bridge cover Zepbound vials?

No. The Bridge covers the Zepbound KwikPen formulation only — not the single-dose vials or single-dose pens. This is a decision about which package Medicare will pay for, not about which one is better or safer. Every Zepbound format contains the same FDA-approved tirzepatide.

A few quick definitions, because the words really matter here:

Medicare GLP-1 BridgeA temporary Medicare program that lets eligible Part D members get certain weight-loss GLP-1 drugs for a flat $50 a month. It runs July 1, 2026 through December 31, 2027.

NDC (National Drug Code)The exact ID number printed on your medicine box. Your pharmacy bills by NDC, not by brand name. That's why "it's all just Zepbound" isn't enough.

KwikPenZepbound's multi-dose pen (it holds about a month of weekly doses in one pen). This is the only Zepbound format the Bridge covers.

Single-dose vial / single-dose penOne dose per container. Neither is covered by the Bridge.

Why so many people get this wrong

Headlines just say “Medicare will cover Zepbound for $50.” Meanwhile, the lowest-priced self-pay Zepbound you’ve probably seen is the vial from LillyDirect. So people naturally assume the $50 deal covers the vials they already use. It doesn’t. The headline is true — but only for the KwikPen. If your first reaction is “finally, a $50 option — wait, not my vials?” you’re not missing something. The rule really is that specific.

Which Zepbound does the Bridge cover, and what are the NDCs?

The Bridge covers Zepbound KwikPen, prescribed for weight loss, for people who meet Medicare’s criteria. CMS publishes the exact set of covered Zepbound NDCs, and your pharmacy matches your package against that list.

Here are the six covered Zepbound KwikPen NDCs from the CMS Bridge page, current as of CMS’s latest update:

Covered Zepbound KwikPen NDCs — Bridge eligible

0002-3566-11

0002-3555-11

0002-3544-11

0002-3533-11

0002-3522-11

0002-3511-11

Source: CMS Medicare GLP-1 Bridge. CMS notes the list may be updated over the course of the program.

We list these exactly as CMS publishes them — as a set. We’re not going to tell you “this code is the 5 mg, that one is the 10 mg,” because CMS releases them together and your pharmacy matches the precise NDC printed on your box. Read the NDC off your label and check it’s one of the six above. If it’s not, that’s your signal that you may be holding a vial or single-dose pen — not the KwikPen.

·A prescription that just says “Zepbound” is not specific enough.

·It needs to be the KwikPen product.

·If your pharmacy is looking at a Zepbound NDC that isn’t on this list, don’t panic that “Medicare denied me.” It may just be the wrong format on file.

See my next step →

Tell us your product and we'll point you to the right path before you call your doctor.

Is the KwikPen the same medicine as my vials?

Yes on the active ingredient and brand; not on the package. Zepbound KwikPen and Zepbound vials are both FDA-approved Zepbound presentations that contain tirzepatide at the same approved doses. But the packaging, the device, the storage and handling, and some product details differ. Don’t treat this as an automatic swap — ask your prescriber whether the KwikPen is right for you.

The reassuring part: you’re not switching to a different drug. You’re switching the container your doctor writes for, so the pharmacy can bill it through the Bridge. The catch: a vial and a pen aren’t used the exact same way, which is why this is a prescriber decision, not a pharmacy-counter paperwork fix.

Detail	Zepbound single-dose vial	Zepbound KwikPen
Active ingredient	Tirzepatide	Tirzepatide
FDA-approved Zepbound?	Yes	Yes
Doses per container	One dose per vial (4 vials = a month)	One pen holds about a month (4 weekly doses)
How it's given	Draw the dose with a syringe	Built-in pen device
Medicare GLP-1 Bridge	Not covered	Covered if you qualify

Source: Eli Lilly Self Pay Journey Program terms — a 1-month supply is 28 days and either 4 single-dose vials or 1 KwikPen.

This “same active ingredient, different format” point is true only because both are FDA-approved brand Zepbound from Eli Lilly. It does not mean a compounded version is the same thing — compounded tirzepatide is a separate category and is not covered by the Bridge at all.

How much does this actually save me?

If you qualify, the Bridge charges a flat $50 a month for the KwikPen, at any dose. Self-pay Zepbound vials through LillyDirect run from $299 to $699 a month depending on dose. Switching to the KwikPen under the Bridge saves most people somewhere between about $250 and $650 a month. Same drug, far lower price — but only for the KwikPen, and only if you’re eligible.

Zepbound dose	LillyDirect regular self-pay	Self Pay Journey (refill on time)	Bridge KwikPen (if eligible)	You’d save
2.5 mg	$299	—	$50	~$249
5 mg	$399	—	$50	~$349
7.5 mg	$499	$449	$50	~$399–$449
10 mg	$699	$449	$50	~$399–$649
12.5 mg	$699	$449	$50	~$399–$649
15 mg	$699	$449	$50	~$399–$649

Sources: Eli Lilly Self Pay Journey Program terms for vial pricing; CMS for the $50 Bridge copay. The Self Pay Journey price ($449 for 7.5–15 mg) applies only if you refill within 45 days; miss that window and you pay the regular price. Verify all prices before relying on them.

The honest catch — read this before you celebrate

The $50 Bridge copay has two real limits, straight from CMS: it does not count toward the running total Medicare uses to move you through your Part D coverage stages, and it does not count toward your yearly out-of-pocket limit (what Medicare calls your true out-of-pocket cost, or TrOOP). On top of that, low-income subsidies — Extra Help — cannot lower the $50.

For most people paying $299–$699 in cash today, that’s a footnote: $50 flat at any dose is a massive drop. But here’s the one group it matters for: if you already have a regular Part D route for a Medicare-covered use — say, Zepbound for moderate-to-severe sleep apnea — and Extra Help makes that copay tiny, the Bridge may not be your cheaper lane. Check your plan’s Part D coverage first.

If that’s you, start with our full Medicare GLP-1 Bridge eligibility guide and your Part D plan.

See if I qualify for the $50 Bridge price →

Free. Five quick questions, then your personalized path — before you book a visit.

Why are the Zepbound vials not covered?

CMS hasn’t said the vials are unsafe or worse — it simply chose the KwikPen as the covered Zepbound format for this program. Treat this as a coverage list, not a medical judgment. There is no public basis for the claim that “vials aren’t trusted” or “the pen is clinically better,” so we won’t say it. The accurate version, in CMS’s own framing: only the Zepbound KwikPen formulation is included in the Bridge, and the single-dose vials and single-dose pens are not.

What this means for you, practically: the vials still exist, and the KwikPen is your road to the $50 price.

Can I still get Zepbound vials outside the Bridge?

Yes. Zepbound vials may still be available through LillyDirect or other self-pay channels with a valid prescription — but that’s a separate cash-pay path, not the $50 Medicare GLP-1 Bridge. If you want the Bridge price, the relevant Zepbound product is the KwikPen. If you’d rather stay on vials, plan on a self-pay route and the prices shown in the table above.

Two clean choices: switch to the KwikPen to chase the $50 Bridge copay, or stay on vials and keep paying cash. Both are legitimate. They’re just different lanes.

Who qualifies for the Medicare GLP-1 Bridge?

You need to be enrolled in an eligible Medicare drug plan for 2026, and you need to meet one of three weight-and-health checkpoints, confirmed by your prescriber on a prior authorization. The drug must be prescribed to reduce excess body weight and maintain weight reduction — not for another condition.

A prior authorization (PA) just means your doctor sends paperwork ahead of time showing you meet the rules. For the Bridge, that paperwork goes to Medicare’s processor (Humana), not to your Part D plan.

Eligible plan types (for calendar year 2026):

Your plan	Bridge eligible?
Standalone Part D drug plan (PDP)	Yes, if you meet the criteria
Medicare Advantage plan with drug coverage (HMO, HMOPOS, Local or Regional PPO)	Yes, if you meet the criteria
Special Needs Plan (SNP), employer/union group plan (EGWP), or LI NET	Yes, if you meet the criteria
Private fee-for-service, cost plan, PACE, fallback, or religious fraternal benefit plan	No — unless also enrolled in a standalone PDP

The three qualifying paths (based on your status when you started GLP-1 therapy):

Path	What you need
1	Age 18+ and a BMI of 35 or higher
2	Age 18+ and BMI 30 or higher, plus one of: a type of heart failure (with preserved ejection fraction), high blood pressure that stays high despite two blood pressure medicines, or chronic kidney disease (stage 3a or higher)
3	Age 18+ and BMI 27 or higher, plus one of: prediabetes, a prior heart attack, a prior stroke, or peripheral artery disease (poor circulation in the limbs) with symptoms

CMS bases this on your numbers at the time GLP-1 therapy began, not your BMI today. So if Zepbound already helped you lose weight, you may still qualify based on where you started — but your prescriber has to attest to that.

For the complete checklist: See the full Medicare GLP-1 Bridge eligibility guide →

What if my Zepbound is for sleep apnea, not weight loss?

Then it does not go through the Bridge. Zepbound is FDA-approved for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. CMS says that when Zepbound is prescribed for a use that’s coverable under basic Part D — like OSA — it does not qualify for Bridge coverage. The path then is regular Part D, your plan’s formulary, or an exception request — not the Bridge.

Why Zepbound is prescribed	Coverage path
Weight loss and maintenance	Bridge — KwikPen, $50/mo, if eligible
Moderate-to-severe sleep apnea (with obesity)	Regular Part D — your plan's formulary and copay
Type 2 diabetes	Usually Mounjaro or Ozempic under Part D, not Zepbound through the Bridge
Not sure	Ask your prescriber which diagnosis is on the prescription

Don’t ask anyone to change a diagnosis to fit a cheaper path. Use the accurate one. If your doctor is treating your sleep apnea, ask your Part D plan about covering Zepbound for OSA instead of forcing the Bridge route.

I’m on Zepbound vials now — exactly what do I do?

If you want the $50 price, ask your prescriber whether switching your prescription to Zepbound KwikPen is right for you, and have them file a Bridge prior authorization. If you’d rather stay on vials, plan on the self-pay route — the Bridge won’t cover them.

I want the $50 Medicare price → Ask your prescriber about the Zepbound KwikPen and confirm you meet the Bridge criteria.

I want to stay on vials → Use the LillyDirect self-pay route. Don't expect Bridge coverage.

My Zepbound is for sleep apnea → Ask your Part D plan about coverage for OSA.

I'm not sure why it was prescribed → Ask your prescriber what's actually on the prescription.

I don't think I qualify for the Bridge → Take our quiz to compare other paths.

Copy this to your prescriber (text it, bring it, or read it at your visit):

“I read that the Medicare GLP-1 Bridge covers Zepbound KwikPen only — not the vials or single-dose pens. If Zepbound is right for me, can we confirm whether the prescription should be for the Zepbound KwikPen, and whether I meet the CMS Bridge criteria so the prior authorization goes to Medicare’s processor?”

What your prescriber needs to line up:

·Product: Zepbound KwikPen (not vial, not single-dose pen)
·Reason: to reduce excess body weight and maintain weight reduction (not OSA, if you're using the Bridge)
·Coverage: you have an eligible Part D or Medicare Advantage drug plan
·Criteria: you meet one of the three qualifying paths
·Routing: the prior authorization goes to the Bridge processor, not your Part D plan

Get my personalized GLP-1 plan →

Free. We map your exact next step — Bridge, Part D, or self-pay — in about a minute.

What if my pharmacy says Zepbound “isn’t covered”?

Don’t assume you were denied. First check two things: that the prescription is the KwikPen, and that the claim is being run as a Bridge claim — not a normal Part D claim. The Bridge uses its own billing route, and if the claim goes to the wrong place, it can look like a rejection when it isn’t.

The Bridge runs through a central processor (Humana) using specific billing codes — BIN 028918 and PCN MEDDGLP1BR. (BIN and PCN are just the routing numbers a pharmacy enters to send a claim to the right payer.) If your pharmacy processes it as a standard Part D claim, it can bounce.

Copy this for your pharmacist:

“This may be a Medicare GLP-1 Bridge claim, not a standard Part D claim. Can you check that the product is the Zepbound KwikPen and that the claim is routing through the Bridge — BIN 028918, PCN MEDDGLP1BR?”

What you hear	What it might mean	Your move
"Zepbound isn't covered"	Could be a vial, a single-dose pen, a sleep-apnea claim, or wrong routing	Check the product, the reason, and the NDC
"Your plan denied the PA"	The PA may have gone to Part D instead of the Bridge	Ask your prescriber to confirm Bridge routing
"Your coupon won't apply"	Coupons and savings cards can't be used on Bridge claims	Don't rely on a savings card here
"Can I pay cash and get reimbursed?"	No — CMS says paper claims and direct member reimbursements are not accepted	Don't pay cash expecting Bridge reimbursement; have the claim routed electronically
"The vial isn't covered"	That's correct under the Bridge	Decide: switch to KwikPen, or pay self-pay

Can Ro or another telehealth service get me the $50 Bridge price?

No — and be careful here. Telehealth weight-loss services like Ro are cash-pay or commercial-insurance programs. They are not Medicare, and they cannot get you the $50 Bridge price. The Bridge runs through your own prescriber and pharmacy, using Medicare’s process. Ro’s own site confirms it works with cash pay and commercial insurance and that it cannot coordinate GLP-1 coverage for government plans like Medicare.

Who is a telehealth service actually useful for? A specific, smaller group:

·You don't qualify for the Bridge and want an FDA-approved brand option.

·You can't wait and want to start before July 1, 2026.

·You want a provider to handle the visit and write a clean KwikPen prescription, and you'll pay cash.

Cash-pay option — not the Medicare GLP-1 Bridge

Affiliate link. For readers who don’t qualify for the Bridge or want to start before July 1. If you qualify for the $50 Bridge, use the Bridge.

If that’s genuinely you, Ro Body (sponsored affiliate link, opens in a new tab) membership is listed at $39 the first month, then $149/month, or as low as $74/month on an annual plan paid upfront. Ro lists the Zepbound KwikPen as a cash-pay option at $299 for the first month, then $399–$449/month (medication and membership are billed separately). This is a cash-pay route, not Medicare. Verify current prices before relying on them.

See Ro’s Zepbound KwikPen cash-pay pricing →

If your only goal is the $50 Medicare price — skip the telehealth route entirely. Go straight to your own prescriber for a KwikPen prescription and a Bridge prior authorization. That’s faster and cheaper for you.

Your situation	Best next step
You qualify for the Bridge and want $50 KwikPen	Your own prescriber + pharmacy, through the Bridge
You have Medicare and want vials	LillyDirect self-pay
You don't qualify and want a brand cash-pay option	A cash-pay telehealth route like Ro
You have commercial insurance (not Medicare)	A telehealth concierge like Ro may help with coverage

Compare my non-Bridge options →

Use this only if you've confirmed the $50 Bridge isn't your path, or you specifically want to stay on vials.

What we verified

Last verified: May 28, 2026. Next scheduled review: June 2026.

✓

The KwikPen-only rule, the vial and single-dose pen exclusion, the six covered Zepbound NDCs, the $50 copay, the TrOOP/Extra Help limits, the coupon rule, the no-paper-claims rule, the OSA-goes-to-Part-D rule, eligible plan types, the clinical criteria, the central processor (Humana), and the BIN/PCN → CMS Medicare GLP-1 Bridge guidance

✓

That Zepbound and Zepbound KwikPen are FDA-approved tirzepatide, the approved doses, and the different presentations (vial, single-dose pen, KwikPen) → DailyMed / FDA labeling

✓

Self-pay pricing and the Self Pay Journey Program 45-day refill terms → Eli Lilly / LillyDirect

✓

That Ro is cash-pay/commercial (not Medicare), its membership pricing, and its Zepbound KwikPen cash price → Ro pricing

We used Reddit and patient forums only to understand where people get confused — never as evidence for coverage, pricing, or medical claims. Two things to re-check before you rely on them: the covered NDCs and the self-pay prices, both of which can change. This page is coverage and pricing information, not medical advice.

Frequently asked questions

Does the Medicare GLP-1 Bridge cover Zepbound vials?

No. CMS includes only the Zepbound KwikPen in the Bridge. Zepbound single-dose vials, including the lower-cost LillyDirect vials, are not covered through the Bridge, even if you personally meet the eligibility rules.

Does the Bridge cover Zepbound single-dose pens?

No. CMS excludes both the single-dose vials and the single-dose pens. The only Zepbound format covered by the Bridge is the KwikPen.

Which Zepbound NDCs are covered by the Bridge?

CMS lists six Zepbound KwikPen NDCs: 0002-3566-11, 0002-3555-11, 0002-3544-11, 0002-3533-11, 0002-3522-11, and 0002-3511-11. CMS can update this list, so confirm your package's NDC is current.

Is the KwikPen the same medicine as the vials?

Same active ingredient and brand, different package. Both are FDA-approved Zepbound (tirzepatide) at the same doses, but the device and handling differ, so treat a switch as a prescriber decision rather than an automatic swap.

How much will Zepbound cost under the Bridge?

A flat $50 a month for the KwikPen at any dose if you qualify, compared with $299 to $699 a month for self-pay vials through LillyDirect.

Does the $50 copay count toward my Part D out-of-pocket costs?

No. CMS says the Bridge copay does not count toward your true out-of-pocket costs (TrOOP) or toward moving you through your Part D phases, and Extra Help cannot lower it.

Can I use a coupon or savings card with the Bridge?

No. Coupons and manufacturer savings cards cannot be applied to Bridge claims. The Bridge has its own $50 copay.

Can I use the Bridge before July 1, 2026?

No. CMS says the Bridge begins July 1, 2026 and runs through December 31, 2027. Before July 1, use regular Part D if the drug is covered for your diagnosis, LillyDirect self-pay, or another non-Bridge path.

Can I pay cash now and get reimbursed by the Bridge later?

No. CMS says the Bridge central processor will not accept paper claims or direct member reimbursements. Do not pay cash expecting Bridge reimbursement; have your pharmacy and prescriber route the claim correctly.

Is the Bridge available in every state?

Yes. CMS says the Bridge is nationwide and available in all states and territories. You still need an eligible plan type, a covered drug and formulation, and a qualifying prior authorization.

Does my doctor have to be enrolled in Medicare to prescribe through the Bridge?

Not necessarily. CMS says a provider does not need to be enrolled in Medicare to write the prescription or submit the Bridge prior authorization, but the provider must not be on the Medicare Preclusion List.

Does Zepbound for sleep apnea go through the Bridge?

No. Zepbound prescribed for moderate-to-severe obstructive sleep apnea runs through your regular Part D plan, not the Bridge.

Can Ro or telehealth get me the $50 Bridge price?

No. Telehealth services like Ro are cash-pay or commercial-insurance programs, not Medicare. The Bridge price comes through your own prescriber and pharmacy. Ro can help if you do not qualify for the Bridge or want a cash-pay brand option.

What if I'm not sure which Zepbound I have?

Read the product name and NDC off your prescription label or box, then check it against the six covered KwikPen NDCs. If it does not match, ask your prescriber or pharmacist before assuming you were denied.

Still not sure which GLP-1 program is right for you? Take our free 60-second matching quiz. It points you to the right path — the Medicare Bridge, regular Part D, LillyDirect self-pay, or a cash-pay option — based on your coverage, your situation, and your budget.

Find my GLP-1 path →

Free. No sign-up. About 60 seconds.

Related guides

Sources

The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. Some links on this page are affiliate links — we may earn a commission if you use them, at no extra cost to you. They never change what we tell you, and they do not apply to the Medicare Bridge path covered here. This page is coverage and pricing information, not medical advice. Confirm your medication, diagnosis, eligibility, and claim routing with your prescriber, your Part D plan, your pharmacist, or CMS before changing your treatment or payment path. Last verified: May 28, 2026.